Catalyst Wire Dossier Catalyst Wire Dossier

Nisoldipine Extended-Release Tablets, 30 mg

nisoldipine · Mylan Pharmaceuticals Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nisoldipine Extended-Release Tablets, 30 mg, covering 2009-09-28 to 2009-09-28. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg [Phase 1]

See pricing